<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Mylan invests $20m more in Mapi&#x27;s monthly Copaxone]]></title><description><![CDATA[<p dir="auto">Mylan invests $20m more in Mapi's monthly Copaxone<br />
<a href="https://en.globes.co.il/en/article-mylan-invests-20m-more-in-mapis-monthly-copaxone-1001332440" rel="nofollow ugc">https://en.globes.co.il/en/article-mylan-invests-20m-more-in-mapis-monthly-copaxone-1001332440</a><br />
Mapi Pharma hopes to manufacture delayed release Copaxone that can be taken twice a month, instead of twice a week with the current version.</p>
<p dir="auto">Saa maa det sidste soem efterhaanden vaere slaaet i den kiste <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=5ae451da0ae" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
<p dir="auto"><img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/84693_TEVA_us_gaap.RevenueFromContractWithCustomerExcludingAssessedTax_us_gaap.ProductOrService_us_gaap.StatementBusinessSegments_teva.NorthAmericaSegment.png" alt="84693_TEVA_us_gaap.RevenueFromContractWithCustomerExcludingAssessedTax_us_gaap.ProductOrService_us_gaap.StatementBusinessSegments_teva.NorthAmericaSegment.png" class=" img-fluid img-markdown" /><br />
<img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/84693_TEVA_us_gaap.RevenueFromContractWithCustomerExcludingAssessedTax_us_gaap.ProductOrService_us_gaap.StatementBusinessSegments_teva.EuropeSegment.png" alt="84693_TEVA_us_gaap.RevenueFromContractWithCustomerExcludingAssessedTax_us_gaap.ProductOrService_us_gaap.StatementBusinessSegments_teva.EuropeSegment.png" class=" img-fluid img-markdown" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/441451/mylan-invests-20m-more-in-mapis-monthly-copaxone</link><generator>RSS for Node</generator><lastBuildDate>Fri, 10 Jul 2026 12:42:46 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/441451.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 15 Jun 2020 18:07:58 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Mylan invests $20m more in Mapi&#x27;s monthly Copaxone on Wed, 17 Jun 2020 16:33:29 GMT]]></title><description><![CDATA[<p dir="auto">Emgality<img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae" class="not-responsive emoji emoji-android emoji--registered" style="height:23px;width:auto;vertical-align:middle" title="®" alt="®" /> Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine<br />
<a href="https://investor.lilly.com/news-releases/news-release-details/emgalityr-demonstrates-reduction-frequency-duration-and-pain" rel="nofollow ugc">https://investor.lilly.com/news-releases/news-release-details/emgalityr-demonstrates-reduction-frequency-duration-and-pain</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459929</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459929</guid><dc:creator><![CDATA[tommycarstensen]]></dc:creator><pubDate>Wed, 17 Jun 2020 16:33:29 GMT</pubDate></item><item><title><![CDATA[Reply to Mylan invests $20m more in Mapi&#x27;s monthly Copaxone on Wed, 17 Jun 2020 06:51:01 GMT]]></title><description><![CDATA[<p dir="auto">Helt enig. Casen er helt on-track.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459931</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459931</guid><dc:creator><![CDATA[MrG]]></dc:creator><pubDate>Wed, 17 Jun 2020 06:51:01 GMT</pubDate></item><item><title><![CDATA[Reply to Mylan invests $20m more in Mapi&#x27;s monthly Copaxone on Tue, 16 Jun 2020 15:33:03 GMT]]></title><description><![CDATA[<p dir="auto">MrG  Den udgoer mindre end 1% af min portefoelje, saa jeg ved ikke, om jeg kan tillade mig at sige, at jeg er med ombord. Ajovy<img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae" class="not-responsive emoji emoji-android emoji--registered" style="height:23px;width:auto;vertical-align:middle" title="®" alt="®" /> uden auto-injektor har vaeret en skuffelse, men ellers gaar det helt efter planen. Jeg har ingen grund til at tro, at de ikke naar i maal inden 2023.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459927</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459927</guid><dc:creator><![CDATA[tommycarstensen]]></dc:creator><pubDate>Tue, 16 Jun 2020 15:33:03 GMT</pubDate></item><item><title><![CDATA[Reply to Mylan invests $20m more in Mapi&#x27;s monthly Copaxone on Tue, 16 Jun 2020 07:17:29 GMT]]></title><description><![CDATA[<p dir="auto">Hej Tommy,<br />
Er du kommet ombord i Teva igen? Casen er helt on-track, og Kåre Schultz har forlænget sin kontrakt, så det virker til, at han vil gøre sit arbejde nogenlunde færdigt dernede.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459924</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459924</guid><dc:creator><![CDATA[MrG]]></dc:creator><pubDate>Tue, 16 Jun 2020 07:17:29 GMT</pubDate></item></channel></rss>